3,0
9 gen 2024
Ex dipendente, più di 5 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Big company without good drugs in the pipeline
Svantaggi
Seems like a different company without Ken Fraiser. Culture is very clickish IT does things the Merck way Not great pay Layoffs attitude about being a big pharma, but no greatness Layoffs on the hush so they dont get bad press EIC plan in Austin - didnt come through for those employees